Oslo, Norway, 6 July 2016: Photocure ASA will present its second quarter report on Tuesday 23 August 2016 at Hotel Continental, Norway, and is proud to announce Dr. Sia Daneshmand as keynote speaker at the event. Dr. Daneshmand will provide an update on Hexvix/Cysview following the new bladder cancer guidelines from American Urological Association (AUA) and the Society of Urological Oncology (SUO), where enhanced cystoscopy including Blue Light Cystoscopy with Hexvix/ Cysview is recommended.

Agenda (CET)
08:30 - 09:05 Q2 presentation by Kjetil Hestdal, President and CEO, and Erik Dahl, CFO
09:05 - 09:15 Break
09:15 - 09:45 Dr. Sia Daneshmand, MD, Associate Professor of Urology (Clinical Scholar); Director of
Urologic Oncology, Director of Research and Fellowship Director, USC Institute of Urology at University of
Southern California, Los Angeles, USA
09:45 - 10:00 Ambaw Bellete, President, Photocure Inc. and Head, US Commercial Operations

A light snack will be served from 08:00.

The presentations will be live streamed at www.photocure.com. More details will be provided later.To attend the presentation, please register by sending an email to gfs@photocure.no.

For further information, please contact:
Photocure
 Erik Dahl, CFO
Tel: +47 450 55 000, Email: ed@photocure.com

Photocure ASA published this content on 06 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 July 2016 07:05:06 UTC.

Original documenthttps://www.photocure.com/Pressmedia/News/2Q2016-save-the-date/

Public permalinkhttp://www.publicnow.com/view/730889E785988F7AB9EDC457A347F0ECC954D062